pyrvinium has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butte, AJ; Chen, B; Chua, MS; Ma, L; Paik, H; Sirota, M; So, S; Wei, W | 1 |
| Germer, CT; Hüttenrauch, M; Krummenast, F; Linnebacher, M; Mühling, B; Otto, C; Thalheimer, A; Uthe, FW; Wiegering, A | 1 |
2 other study(ies) available for pyrvinium and Liver Neoplasms
| Article | Year |
|---|---|
Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets.
Topics: Animals; Antineoplastic Agents; Female; Gene Expression; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Nude; Pyrvinium Compounds; Systems Biology; Xenograft Model Antitumor Assays | 2017 |
The impact of pyrvinium pamoate on colon cancer cell viability.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Cell Line, Tumor; Cell Movement; Cell Survival; Colonic Neoplasms; Fluorouracil; Genes, APC; Heterografts; Humans; Inhibitory Concentration 50; Liver Neoplasms; Mice; Pyrvinium Compounds; Wnt Signaling Pathway | 2014 |